June 2010 Vol XXXIV Issue 6
VIRAL HEPATITIS, SERIES #11
Treatment of Hepatitis C in the Pre-DAA's Era: Treat Now or Wait for New Medications?This paper presents the advantages and disadvantages of treating HCV now with available therapy versus waiting for promising new therapeutic compounds on the horizon. Also provided here is a framework for physicians to discuss treatment alternatives with their patients.
ENDOSCOPY: OPENING NEW EYES, SERIES #4
Radiofrequency Ablation: An OverviewIf untreated, approximately 10% of Barrett's esophagus patients may develop esophageal adenocarcinoma. This article summarizes recent data regarding the efficacy and safety of radiofrequency ablation in the treatment of BE. The indications, technical aspects, and cost-effectiveness are also reviewed.
Departments Section
Immunosuppression Impairs Response to Vaccination in IBD
To assess the impact of immunosuppression on immune responses to pneumococcal vaccination in patients with IBD, a prospective controlled clinical trial was carried out at a tertiary-care IBD clinic.
Coffee Consumption and Hepatic Fibrosis
Coffee consumption has been associated with reduced frequency of liver disease. A study was undertaken to use a food-frequency instrument for dietary caffeine consumption to evaluate the relationship between caffeine intake and liver fibrosis.
A Winning Combination: Prebiotic Fiber and Probiotic Bacteria Team Up for Digestive Health
Bayer Consumer Care Launches PhillipsTM Colon Health® Probiotic + Fiber
Study Shows Endoscopic Duodenal Stenting Is Associated With Lower Cos
Results of Study Using Boston Scientific’s WallFlex® Duodenal Stent Presented at Digestive Disease Week®
Viral Hepatitis Summits Coming to a City Near You!
The Hepatitis Foundation International has scheduled four more Viral Hepatitis Summits to be held in Atlanta in September,and New Orleans, Indianapolis and Richmond in October.
